Biotechnology - Neurological, Anti-Arthritics/Rheumatics

Filter

Popular Filters

Abbott in further deal with Reata

12-12-2011

US health care major Abbott Laboratories (NYSE: ABT) has entered into a second mega-million dollar licensing…

Abbott LaboratoriesAnti-Arthritics/RheumaticsbardoxoloneBiotechnologyLicensingNeurologicalPharmaceuticalReata Pharmaceuticals

Company Spotlight

ImmunoGen

ImmunoGen

Back to top